- AU$112.77m
- AU$105.69m
- AU$1.16m
- 29
- 12
- 44
- 18
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.74 | ||
| Price to Tang. Book | 9.74 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 86.74 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -42.76% | ||
| Return on Equity | -35.59% | ||
| Operating Margin | -381.38% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 1.19 | 0.89 | 1.01 | 1.68 | 1.16 | n/a | n/a | 1.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Company’s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 11th, 1997
- Public Since
- August 8th, 1997
- No. of Shareholders
- 3,715
- No. of Employees
- 8
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 835,340,803
- Address
- 16 Miles Street, MULGRAVE, 3170
- Web
- https://www.optiscan.com/
- Phone
- +61 395383333
- Auditors
- William Buck Audit (Vic) Pty Ltd
Upcoming Events for OIL
Similar to OIL
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the Optiscan Imaging share price?
As of Today at 22:28 UTC, shares in Optiscan Imaging are trading at AU$0.14. This share price information is delayed by 15 minutes.
How has the Optiscan Imaging share price performed this year?
Shares in Optiscan Imaging last closed at AU$0.14 and the price had moved by +58.82% over the past 365 days. In terms of relative price strength the Optiscan Imaging share price has outperformed the ASX All Ordinaries Index by +53.07% over the past year.
What are the analyst and broker recommendations for Optiscan Imaging?
There is no consensus recommendation for this security.
Find out moreWhat is the Optiscan Imaging dividend yield?
Optiscan Imaging does not currently pay a dividend.
Does Optiscan Imaging pay a dividend?
Optiscan Imaging does not currently pay a dividend.
When does Optiscan Imaging next pay dividends?
Optiscan Imaging does not currently pay a dividend.
How do I buy Optiscan Imaging shares?
To buy shares in Optiscan Imaging you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Optiscan Imaging?
As of the previous close price of AU$0.14, shares in Optiscan Imaging had a market capitalisation of AU$112.77m.
Where are Optiscan Imaging shares listed?
Here are the trading details for Optiscan Imaging:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: OIL
What kind of share is Optiscan Imaging?
Based on an overall assessment of its quality, value and momentum Optiscan Imaging is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Optiscan Imaging share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Optiscan Imaging share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Optiscan Imaging. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -15.83%.
As of the last closing price of AU$0.14, shares in Optiscan Imaging were trading -19.04% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Optiscan Imaging PE Ratio?
The Optiscan Imaging PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Optiscan Imaging?
Optiscan Imaging's management team is headed by:
- Robert Cooke - NEC
- Camile Farah - CEO
- Karen Borg - NED
- Ron Song - NED